NASDAQ:IOVA
Iovance Biotherapeutics, Inc. Stock News
$10.24
-0.190 (-1.82%)
At Close: May 17, 2024
Adding One More Dimension In Solid Tumor Therapy - Iovance Biotherapeutics
11:38am, Wednesday, 24'th Jun 2020
IOVA’s tumor infiltrating lymphocyte (TIL) therapy showed promising efficacy in metastatic melanoma. The TIL platform has the potential to expand to many other
Neoleukin Therapeutics (NLTX) Receives a Buy from Mizuho Securities - Markets
02:17am, Wednesday, 24'th Jun 2020
Mizuho Securities analyst Mara Goldstein reiterated a Buy rating on Neoleukin Therapeutics (NLTX – Research Report) yesterday and set a
Tissue-Like Pressure Sensors Key to Bionic Breast Project
12:03pm, Tuesday, 23'rd Jun 2020
Approximately one third of the 3.8 million female breast cancer survivors in the US today have undergone mastectomy, and as many as three quarters of women with breast cancer are affected by sexual dy
‘Hangover’ was cluster of blood clots on my brain - caused by the Pill
10:48am, Tuesday, 23'rd Jun 2020
A WOMAN has urged others to reconsider taking the contraceptive pill after she was left with a cluster of blood clots on her brain. Lucie Edwards thought she was suffering from a bad hangover after…
Deforestation’s Link To Outbreaks: ‘When You Disturb A Forest, It Actually Upsets The Balance Of Nature’
11:34am, Monday, 22'nd Jun 2020
Scientists are seeing a disturbing trend between an increase in deforestation and a surge of new diseases. Six out of every 10 diseases in humans, and three-quarters of the world’s emerging i…
Lineage Cell Therapeutics (LCTX) Gets a Buy Rating from H.C. Wainwright - Markets
11:33am, Monday, 22'nd Jun 2020
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Lineage Cell Therapeutics (LCTX – Research Report) on June 18
Vertical vs. Horizontal AI Startups
02:10am, Sunday, 21'st Jun 2020
AI Startups come in two distinct flavors. What to keep in mind when going for either kind.
Iovance Biotherapeutics Inc (NASDAQ:IOVA) Given Average Rating of “Buy” by Analysts
06:40am, Saturday, 20'th Jun 2020
Shares of Iovance Biotherapeutics Inc (NASDAQ:IOVA) have received an average rating of “Buy” from the seventeen research firms that are covering the stock, Marketbeat reports. Two research analyst
M&T Bank Corp Cuts Stock Position in Iovance Biotherapeutics Inc (NASDAQ:IOVA)
05:58am, Saturday, 20'th Jun 2020
M&T Bank Corp decreased its holdings in shares of Iovance Biotherapeutics Inc (NASDAQ:IOVA) by 10.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Co
Aerial yoga at 75, Pilates and diving too – he’s ageing well
01:15am, Saturday, 20'th Jun 2020
Your source for credible news and authoritative insights from Hong Kong, China and the world.
Food and Drug Administration temporarily delays Lehi antibody testing
12:00am, Saturday, 20'th Jun 2020
Weeks after the U.S. Food and Drug Administration granted emergency use authorization of the Chembio Diagnostic System, Inc. COVID-19 antibody test, the FDA revoked nationwide authorization, halting a
Delhi cases cross 50,000, 66 more deaths
09:45pm, Friday, 19'th Jun 2020
According to the health bulletin, 5,883 patients are admitted to hospitals. Visiting the upcoming 700-bed hospital in Burari, Chief Minister Arvind Kejriwal said “every third bed at the hospital wil
The COVID-19 pandemic may have an unexpected impact: A dramatic increase in cancer deaths
05:42pm, Friday, 19'th Jun 2020
A leading cancer doctor blames delayed cancer screenings, treatments and halted research for the anticipated surge in cancer deaths.
